INS and metabolic dysfunction-associated steatotic liver disease: N. sativa supplementation (2 g/day for 12 weeks) in patients who have cardiovascular disorders risk factors and also in patients with NAFLD 2 significantly decreased glucose and insulin serum levels and also decreased hepatic steatosis percentage compared to the placebo [140].